Company profile: NanoMR
1.1 - Company Overview
Company description
- Provider of blood diagnostic devices and an immunomagnetic capture system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower, enabling simultaneous targeting of multiple cell types, including bacteria and fungi from bloodstream infections, as well as specific cells such as circulating tumor and fetal cells.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NanoMR
Teneobio
HQ: United States
Website
- Description: Provider of human heavy chain antibody discovery and development, with pre-clinical and clinical programs for multiple myeloma, prostate cancer, and immune disorders. Its antibody discovery engine is based on UniRat™.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Teneobio company profile →
Xlife Sciences
HQ: Switzerland
Website
- Description: Provider of development and commercialization of early-stage life sciences research from universities and research institutions, bridging R&D to healthcare markets. Offers technology platforms, biotechnologies and therapies addressing unmet medical needs, medical technologies, artificial intelligence in life sciences, and digital health projects to enhance healthcare and life quality.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xlife Sciences company profile →
PreOmics
HQ: Germany
Website
- Description: Provider of innovative pre-analytics and sample preparation technologies for MS-based proteomics, supporting researchers in protein analysis. Offerings include iST kits for protein/peptide prep, TMT/iTRAQ-compatible chemical labeling (iST-NHS), minimized modifications in biofluids (iST-BCT), high-throughput positive-pressure prep (iST-PSI), peptide clean-up (iST Phoenix), and GFP IP enrichment (iST-Trap).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PreOmics company profile →
GenScript
HQ: United States
Website
- Description: Provider of contract research services specialized in biological research and drug discovery/development, offering gene synthesis with expression optimization, cloning and subcloning, plasmid DNA preparation for research, industrial and clinical applications, custom CRISPR-Cas9 gene editing, peptide synthesis, and ToxinSensor kits for sensitive, low-cost endotoxin detection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenScript company profile →
Cevec
HQ: Germany
Website
- Description: Provider of biopharmaceutical production expertise using a unique human cell-based expression system, developing therapeutic proteins and monoclonal antibodies with human glycosylation patterns. CAP-Go enables production of proteins beyond antibodies, including complex glycosylated proteins that are difficult to express in conventional cell lines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cevec company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NanoMR
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NanoMR
2.2 - Growth funds investing in similar companies to NanoMR
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NanoMR
4.2 - Public trading comparable groups for NanoMR
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →